NF EN ISO 25539-1
Cardiovascular implants - Endovascular devices - Part 1 : endovascular prostheses
ISO 25539-1:2017 specifies requirements for the evaluation of endovascular systems (prostheses and delivery systems) and requirements with respect to nomenclature, design attributes and information supplied by the manufacturer based upon current medical knowledge. Guidance for the development of in vitro test methods is included in an informative annex to this document. This document can be considered as a supplement to ISO 14630, which specifies general requirements for the performance of non-active surgical implants.ISO 25539-1:2017 is applicable to endovascular systems used to treat aneurysms, stenoses or other vascular anomalies or pathologies (e.g. dissections, transections) or to create shunts between vessels [e.g. creation of transjugular intrahepatic portosystemic shunting (TIPS)]. Some of the requirements are specific to endovascular treatment of arterial aneurysms or stenoses. Although uses of endovascular systems other than treatment of arterial aneurysms or stenoses (e.g. dissections, transections, shunts) are within the scope of this document, the specific requirements and testing are not described. Similarly, specific prosthesis configurations (e.g. fenestrated, branched) are within the scope, but specific requirements and testing are not described for these devices.ISO 25539-1:2017 is not applicable to vascular occluders, with the exception of contra-lateral iliac artery occluders when used as an integral part of aorto-uni-iliac endovascular prosthesis. Although contra-lateral iliac artery occluders when used as an integral part of aorto-uni-iliac endovascular prosthesis are within the scope of this document, specific requirements and testing are not described for these devices.Balloons used to achieve adequate apposition of the prosthesis with the vessel wall or overlapping components are within the scope of this document, even if they are not integral to the endovascular system. This document provides requirements beyond the requirements of ISO 10555‑4, specific to the use of balloons with endovascular prostheses.ISO 25539-1:2017 is not applicable to procedures and devices used prior to the introduction of the endovascular system, such as balloon angioplasty devices.The valve component of valved conduits constructed with an endovascular prosthesis component and the combination of the valved component and the endovascular prosthesis component are excluded from the scope of this document. This document can be helpful in identifying the appropriate evaluation of the endovascular prosthesis component of a valved conduit, but specific requirements and testing are not described for these devices.NOTE 1 Cardiac valved conduits are within the scope of ISO 5840‑1.Pharmacological aspects of drug eluting or drug coated endovascular prostheses are not addressed in this document.NOTE 2 Vascular device-drug combination products are within the scope of ISO 12417.ISO 25539-1:2017 does not address the requirements for, and the evaluation of, viable tissues and non-viable biologic materials used in the construction of endovascular prostheses.The requirements for, and the evaluation of, degradation and other time-dependant aspects of absorbable materials used in the construction of endovascular prostheses are not addressed in this document.NOTE 3 Absorbable materials are within the scope of ISO/TS 17137 and ISO/TR 37137.
ISO 25539-1:2017 specifies requirements for the evaluation of endovascular systems (prostheses and delivery systems) and requirements with respect to nomenclature, design attributes and information supplied by the manufacturer based upon current medical knowledge. Guidance for the development of in vitro test methods is included in an informative annex to this document. This document can be considered as a supplement to ISO 14630, which specifies general requirements for the performance of non-active surgical implants.
ISO 25539-1:2017 is applicable to endovascular systems used to treat aneurysms, stenoses or other vascular anomalies or pathologies (e.g. dissections, transections) or to create shunts between vessels [e.g. creation of transjugular intrahepatic portosystemic shunting (TIPS)]. Some of the requirements are specific to endovascular treatment of arterial aneurysms or stenoses. Although uses of endovascular systems other than treatment of arterial aneurysms or stenoses (e.g. dissections, transections, shunts) are within the scope of this document, the specific requirements and testing are not described. Similarly, specific prosthesis configurations (e.g. fenestrated, branched) are within the scope, but specific requirements and testing are not described for these devices.
ISO 25539-1:2017 is not applicable to vascular occluders, with the exception of contra-lateral iliac artery occluders when used as an integral part of aorto-uni-iliac endovascular prosthesis. Although contra-lateral iliac artery occluders when used as an integral part of aorto-uni-iliac endovascular prosthesis are within the scope of this document, specific requirements and testing are not described for these devices.
Balloons used to achieve adequate apposition of the prosthesis with the vessel wall or overlapping components are within the scope of this document, even if they are not integral to the endovascular system. This document provides requirements beyond the requirements of ISO 10555‑4, specific to the use of balloons with endovascular prostheses.
ISO 25539-1:2017 is not applicable to procedures and devices used prior to the introduction of the endovascular system, such as balloon angioplasty devices.
The valve component of valved conduits constructed with an endovascular prosthesis component and the combination of the valved component and the endovascular prosthesis component are excluded from the scope of this document. This document can be helpful in identifying the appropriate evaluation of the endovascular prosthesis component of a valved conduit, but specific requirements and testing are not described for these devices.
NOTE 1 Cardiac valved conduits are within the scope of ISO 5840‑1.
Pharmacological aspects of drug eluting or drug coated endovascular prostheses are not addressed in this document.
NOTE 2 Vascular device-drug combination products are within the scope of ISO 12417.
ISO 25539-1:2017 does not address the requirements for, and the evaluation of, viable tissues and non-viable biologic materials used in the construction of endovascular prostheses.
The requirements for, and the evaluation of, degradation and other time-dependant aspects of absorbable materials used in the construction of endovascular prostheses are not addressed in this document.
NOTE 3 Absorbable materials are within the scope of ISO/TS 17137 and ISO/TR 37137.
Le présent document spécifie les exigences relatives aux prothèses endovasculaires. En matière de sécurité, il définit les exigences des performances prévues, des caractéristiques de conception, des matériaux, de l'évaluation de conception, ainsi que la fabrication, la stérilisation, l'emballage et les informations fournies par le fabricant. Il inclut les prothèses endovasculaires utilisées dans le traitement des anévrysmes artériels, des sténoses artérielles ou d'autres anomalies vasculaires. Il inclut aussi les systèmes de largage s'ils font partie intégrante du système de mise en place des prothèses endovasculaires. Parmi les dispositifs d'occlusion vasculaire, seuls les dispositifs d'occlusion iliaque contralérale utilisés comme partie intégrante d'un dispositif aorto-uni-iliaque sont abordés. Il ne s'applique pas aux techniques et dispositifs utilisés avant l'introduction du système endovasculaire, tels que les dispositifs d'angioplastie transluminate percutanée. Le présent document a été élaboré dans le but de se conformer aux exigences essentielles de la Directive européenne 93/42/CE sur les dispositifs médicaux.
-
1 Domaine d'application
-
2 Références normatives
-
3 Termes et définitions
-
4 Exigences générales du système endovasculaire
-
5 Performances prévues
-
6 Caractéristiques de conception
-
7 Matériaux
-
8 Évaluation de la conception
-
9 Surveillance après la mise sur le marché
-
10 Fabrication
-
11 Stérilisation
-
12 Emballage
- Annexe A Relation entre les exigences d'essai, les caractéristiques du dispositif et les modes de défaillance potentiels
- Annexe B Description des effets sur le dispositif et des effets cliniques d'une défaillance
- Annexe C Essais au banc et analytiques
- Annexe D Méthodes d'essai
- Bibliographie
The Requirements department helps you quickly locate within the normative text:
- mandatory clauses to satisfy,
- non-essential but useful clauses to know, such as permissions and recommendations.
The identification of these types of clauses is based on the document “ISO / IEC Directives, Part 2 - Principles and rules of structure and drafting of ISO documents ”as well as on a constantly enriched list of verbal forms.
With Requirements, quickly access the main part of the normative text!

At a glance, you will be able to identify the additions, deletions or modifications to a text, table, figure and formula.

The Redlines + service is offered to you on the collection of French standards in force, in French language and in HTML and PDF format.
For an overview of the service, click on View a standard in redline format
COBAZ is the simple and effective solution to meet the normative needs related to your activity, in France and abroad.
Available by subscription, CObaz is THE modular solution to compose according to your needs today and tomorrow. Quickly discover CObaz!
Request your free, no-obligation live demo
I discover COBAZ